Biodel Inc. (BIOD) Reports Second Quarter Fiscal Year 2013 Financial Results
5/8/2013 9:31:35 AM
More...
|
Biodel Inc. (BIOD) to Report Second Quarter Fiscal Year 2013 Financial Results on May 8, 2013
5/6/2013 9:41:37 AM
More...
|
Biodel Inc. (BIOD)l Reports Positive Top-Line Results From Clinical Study of Ultra-Rapid-Acting Insulin Analog Candidates
1/24/2013 7:27:30 AM
More...
|
Biodel Inc. (BIOD) Reports Fourth Quarter Fiscal Year 2012 Financial Results
12/18/2012 8:54:16 AM
More...
|
Biodel Inc. (BIOD) to Report Fourth Quarter Fiscal Year 2012 Financial Results on December 18, 2012
12/14/2012 9:57:26 AM
More...
|
FDA Grants Orphan Drug Designation to Biodel Inc. (BIOD)l's Glucagon for Prevention of Hypoglycemia in Congenital Hyperinsulinism Population
12/7/2012 9:41:11 AM
More...
|
Biodel Inc. (BIOD) to Host Analyst / Investor Research and Development Meeting on October 11th in New York
10/8/2012 10:09:15 AM
More...
|
Biodel Inc. (BIOD) to Present at European Association for the Study of Diabetes on October 2, 2012 in Berlin, Germany
9/27/2012 10:33:28 AM
More...
|
Biodel Inc. (BIOD) Awarded National Institutes of Health (NIH) Grant to Develop Glucagon Formulations for Use in Artificial Pancreas
9/24/2012 9:49:48 AM
More...
|
Biodel Inc. (BIOD) Announces Phase 2 Clinical Trial Initiation of Ultra-Rapid-Acting Insulin Candidate BIOD-123
9/13/2012 9:50:21 AM
More...
|
|